Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

6 Jul 2007 07:01

Cello Group plc06 July 2007 6 July 2007 Cello Group plc Cello expands financial services capability with the acquisition of cchm:ping Cello Group plc ("Cello", AIM: CLL), the market research and consulting group,has acquired a controlling interest in Hill Murray Group Limited, the holdingcompany of cchm:ping Limited ("cchm:ping"), a specialist financial servicesmarketing agency with options to acquire the balance of the shares. The totalmaximum consideration for the acquisition of 100% of Hill Murray Group Limitedis approximately £5.3 million in cash, loan notes and new ordinary shares. cchm:ping, which was established in 1997, has a number of blue chip financialservices clients including Aegon, Bristol & West Mortgages, Legal & General,Nationwide, Lloyds TSB & Scottish Life. Cello has acquired just over 76% of cchm:ping for an initial consideration ofapproximately £0.95 million of which £0.76 million is payable in cash and thebalance satisfied by the issue of 127,307 new ordinary shares. The remaining 24%is subject to put and call options exercisable in the period 2008 to 2011 withthe option prices being determined by the financial performance of cchm:pingduring the period to 31 December 2010. The option consideration is payable incash, loan notes and new ordinary shares with a minimum amount to be settled incash, loan notes varying from 80% for an option exercised in 2008 to 25% for anoption exercised in 2011. As part of the transaction Cello has also agreed to acquire a controllinginterest (60% on a fully diluted basis) in the issued share capital of thefinancial services consultancy, The Consultancy Practice Limited. The remainingminority interest is the subject of a put option whereby Cello can be requiredto purchase the 40% minority interest at any time in the period from March 2010to March 2013. The option consideration is payable in a mixture of cash, loannotes and new ordinary shares at Cello's discretion with a minimum loan noteconsideration of 25% for an option exercised before March 2011 and 35%thereafter. The maximum option consideration price is £1.75million and is basedon demanding performance related criteria. For the year to 30 September 2006, cchm:ping had an audited turnover of £8.0million, gross profits of £5.6million and delivered a loss before tax of £0.3million. Net assets as at 30 September 2006 were £0.7 million including cash of£0.6 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 12 July2007. Kevin Steeds, Cello Chairman, said: "cchm:ping is a highly regarded specialist financial services marketing agencywith an excellent client base. As part of our Response division, based inLondon, it will complement our existing business and give us considerably moredepth in the financial services sector vertical." Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building a portfolioof research and consulting businesses capable of advising blue chip clientsglobally. Cello has annualised turnover in excess of £90million, gross profits of over £50million and employs approx 550 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jul 20204:59 pmPRNForm 8.3 - Cello Health Plc
6th Jul 20203:45 pmRNSForm 8.3 - Cello Health plc
6th Jul 20203:13 pmRNSForm 8.3 - CELLO HEALTH PLC
6th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
6th Jul 202012:15 pmRNSForm 8.3 - Cello Health Plc
6th Jul 20207:00 amRNSUpdate on irrevocable undertakings
3rd Jul 20203:20 pmRNSForm 8.3 - Cello Health
3rd Jul 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
3rd Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
3rd Jul 20202:30 pmRNSForm 8.3 - Cello Health PLC
3rd Jul 202011:53 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20209:36 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20207:00 amRNSReplacement - Form 8 (OPD) - Cello Health plc
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20206:26 pmRNSForm 8.3 - Cello Health plc
2nd Jul 20203:20 pmRNSForm 8.3 - Cello Health
2nd Jul 20202:29 pmRNSForm 8.3 - CELLO GROUP PLC
2nd Jul 20201:07 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202012:17 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202010:57 amRNSForm 8.3 - CELLO HEALTH PLC
2nd Jul 202010:26 amGNWForm 8.3 - [Cello Health plc - Opening Declaration] - (HH Ltd)
2nd Jul 202010:25 amRNSForm 8.3 - Cello Health Plc
2nd Jul 20208:53 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20207:00 amRNSUpdate on letters of intent
2nd Jul 20207:00 amRNSForm 8 (OPD) - Cello Health plc
1st Jul 20205:21 pmGNWForm 8.3 - Cello Health plc
1st Jul 20203:31 pmPRNForm 8.3 - Cello Health
1st Jul 20209:05 amRNSForm 8.3 - Cello Health plc
1st Jul 20207:00 amRNSRECOMMENDED CASH OFFER
15th Jun 202010:09 amRNSHolding(s) in Company
11th Jun 20203:48 pmRNSHolding(s) in Company
20th May 20201:05 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement
5th May 20207:00 amRNSIssue of Equity
21st Apr 20207:00 amRNSAnnual Report and Notice of AGM
17th Apr 20209:46 amRNSTotal Voting Rights
14th Apr 20205:18 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:37 amRNSGrant of Options
18th Mar 20207:00 amRNSPreliminary Results
7th Feb 202012:19 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSSettlement with Access Intelligence
22nd Jan 20204:40 pmRNSBlock listing Interim Review
16th Jan 20207:00 amRNSPre-Close Trading Statement
3rd Dec 20193:09 pmRNSTotal Voting Rights
22nd Nov 20194:55 pmRNSHolding(s) in Company
14th Nov 20199:30 amRNSHolding(s) in Company
13th Nov 20195:00 pmRNSTotal Voting Rights
7th Oct 20191:39 pmRNSHolding(s) in Company
7th Oct 20191:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.